Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122101987 | 12210198 | 7 | F | 20160210 | 20160713 | 20160325 | 20160726 | EXP | US-PFIZER INC-2016175197 | PFIZER | 68.00 | YR | F | Y | 55.78000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122101987 | 12210198 | 1 | PS | LATANOPROST. | LATANOPROST | 1 | 1 DROP IN BOTH EYES DAILY AT BEDTIME | Y | M53895 | 20597 | 2 | GTT | EYE DROPS, SOLUTION | ||||||
| 122101987 | 12210198 | 2 | SS | LATANOPROST. | LATANOPROST | 1 | UNK | Y | M52633 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 122101987 | 12210198 | 3 | SS | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | 0.005 %, UNK (1 DROP IN EACH EYE AT BEDTIME) | Y | M53895, M52633 | 20597 | .005 | PCT | EYE DROPS, SOLUTION | |||||
| 122101987 | 12210198 | 4 | SS | LATANOPROST. | LATANOPROST | 1 | UNK | Y | 20597 | EYE DROPS, SOLUTION | |||||||||
| 122101987 | 12210198 | 5 | SS | LATANOPROST. | LATANOPROST | 1 | 0.005 UNK, UNK | Y | 20597 | .005 | PCT | EYE DROPS, SOLUTION | |||||||
| 122101987 | 12210198 | 6 | SS | LATANOPROST. | LATANOPROST | 1 | ONE DROP TO RIGHT EYE THREE TIMES A DAY | Y | M13902 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 122101987 | 12210198 | 7 | SS | LATANOPROST. | LATANOPROST | 1 | UNK | Y | M13902 | 20597 | EYE DROPS, SOLUTION | ||||||||
| 122101987 | 12210198 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10MG ONCE A DAY BY MOUTH | 0 | 10 | MG | TABLET | QD | ||||||
| 122101987 | 12210198 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122101987 | 12210198 | 8 | Blood cholesterol increased |
| 122101987 | 12210198 | 9 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122101987 | 12210198 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122101987 | 12210198 | Blindness | |
| 122101987 | 12210198 | Drug intolerance | |
| 122101987 | 12210198 | Exophthalmos | |
| 122101987 | 12210198 | Eye disorder | |
| 122101987 | 12210198 | Eye infection | |
| 122101987 | 12210198 | Eye irritation | |
| 122101987 | 12210198 | Eye pain | |
| 122101987 | 12210198 | Eye swelling | |
| 122101987 | 12210198 | Lacrimation increased | |
| 122101987 | 12210198 | Product use issue | |
| 122101987 | 12210198 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122101987 | 12210198 | 5 | 20160227 | 20160228 | 0 | |
| 122101987 | 12210198 | 6 | 20160420 | 20160420 | 0 |